CWP
MDLN

Concord Wealth Partners’s Medline Inc MDLN Stock Holding History

Concord Wealth Partners’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.86K Buy
+250
New +$10.1K ﹤0.01% 574
2026
Q1 		– Sell
-250
Closed -$10.5K – 849
2025
Q4 		$10.5K Buy
+250
New +$10.6K ﹤0.01% 529

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Concord Wealth Partners's MDLN Position: Q2 2026 in Review

Concord Wealth Partners opened a new position in Medline Inc (MDLN) in Q2 2026: 250 shares worth $9.86K. The stake represents ﹤0.01% of the portfolio and ranks #574 among its holdings. This is a return to the name: Concord Wealth Partners previously reported a position in MDLN as recently as Q4 2025.

Concord Wealth Partners first reported a position in MDLN in Q4 2025 and has held it in 2 quarters since. The position peaked at $10.5K in Q4 2025. 407 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Concord Wealth Partners held 250 shares of Medline Inc worth $9.86K as of Q2 2026.
  • Medline Inc was a new Concord Wealth Partners position in Q2 2026.
  • Medline Inc made up ﹤0.01% of Concord Wealth Partners's portfolio in Q2 2026, its #574 holding.
  • Concord Wealth Partners first reported a position in Medline Inc in Q4 2025 and has held it in 2 quarters since.
  • Concord Wealth Partners's Medline Inc position peaked at $10.5K in Q4 2025.
  • 407 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Concord Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.